<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/06/02/hot-investor-mandate-venture-arm-of-large-drug-development-organization-supports-drug-discovery-companies-with-seed-and-later-stage-investments/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T16:52:22+00:00</news:publication_date><news:title>Hot Investor Mandate: Venture Arm of Large Drug Development Organization Supports Drug Discovery Companies With Seed and Later-Stage Investments </news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/02/hot-investor-mandate-multi-stage-healthcare-investment-firm-seeks-early-clinical-stage-therapeutics-and-devices-near-regulatory-approval-investing-up-to-20m/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T16:51:43+00:00</news:publication_date><news:title>Hot Investor Mandate: Multi-Stage Healthcare Investment Firm Seeks Early Clinical Stage Therapeutics and Devices Near Regulatory Approval, Investing Up to $20M</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/02/hot-investor-mandate-usa-based-vc-firm-focuses-on-deeptech-and-techbio-investments-in-pre-seed-to-series-a-rounds/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T16:51:24+00:00</news:publication_date><news:title>Hot Investor Mandate: USA-Based VC Firm Focuses on Deeptech and Techbio Investments in Pre-Seed to Series A Rounds</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/02/hot-investor-mandate-cvc-arm-of-leading-healthcare-company-allocates-up-to-10m-in-growth-stage-therapeutics-and-diagnostics-companies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T16:50:31+00:00</news:publication_date><news:title>Hot Investor Mandate: CVC Arm of Leading Healthcare Company Allocates Up to $10M in Growth-Stage Therapeutics and Diagnostics Companies</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/02/investors-presenting-at-resi-san-diego/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T13:06:46+00:00</news:publication_date><news:title>Investors Presenting at RESI San Diego</news:title><news:keywords>venture capital, Healthcare, news, technology, startups, health, travel, AI, business, entrepreneurship, food, finance, investing, books</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/02/resi-innovators-pitch-challenge-winner-amets-biotechnology-on-advancing-gene-therapies-for-rare-diseases/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T12:43:46+00:00</news:publication_date><news:title>RESI Innovator’s Pitch Challenge Winner Amets Biotechnology on Advancing Gene Therapies for Rare Diseases </news:title><news:keywords>technology, marketing, business, entrepreneurship, digital-marketing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/02/what-investors-need-to-hear-turning-your-pitch-into-investor-signal/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T12:19:36+00:00</news:publication_date><news:title>What Investors Need to Hear: Turning Your Pitch into Investor Signal </news:title><news:keywords>venture capital, startup, technology, startups, business, entrepreneurship, finance, leadership</news:keywords></news:news></url></urlset>